←
Liang Wang495 posts
Liang Wang avatar

Liang Wang

@_wangliang

Professor & PI Laboratory Medicine | Smart Diagnostics LE: J Appl Microbiol AE: J Transl Med, Front Microbiol EBM: BMC Micro, JoVE, PeerJ

◷ Joined February 2019▧ 157 Photos and videos
Liang Wang avatar
Liang Wang@_wangliang·16 Sep 2025

Thrilled to announce my election as Chairperson of the Microbiology and Clinical Infection Professional Committee of the Guangdong Province Hospital Association

Post attachmentPost attachmentPost attachmentPost attachment
Liang Wang avatar
Liang Wang@_wangliang·Nov 12

Honored to join #ICID2026 in Madrid as an invited speaker on Artificial Intelligence and Infectious Diseases and as session chair for Innovations and Clinical Updates in Infectious Disease Diagnostics. Great discussions with the global ID community. Thank you @ISID_org ! #ISID #InfectiousDiseases

Post attachmentPost attachment
Liang Wang avatar
Liang Wang@_wangliang·Nov 4

Delighted to be in Ho Chi Minh City for CHRO 2026 – the 23rd International Conference on Campylobacter, Helicobacter, and Related Organisms. It has been an honour to contribute in several capacities: as an invited speaker, as session chair, and as Lead Editor of the Journal of Applied Microbiology (Microbiology in Health and Disease theme). The journal is the official publication of Applied Microbiology International (AMI), which is proud to be one of the conference sponsors this year. A pleasure to engage with colleagues from around the world as we mark 30 years since the sequencing of the H. pylori genome and continue advancing research from genomics to precision medicine. #CHRO2026 #Helicobacter #Campylobacter #AppliedMicrobiology #JournalofAppliedMicrobiology #Microbiology #ScientificCommunity

Post attachment
Liang Wang avatar
Liang Wang@_wangliang·Oct 11

Global research priority exercise: top needs are rapid, low-cost point-of-care tests that detect infection and resistance together, plus cost-effective population screen-and-treat programs.

Liang Wang avatar
Liang Wang@_wangliang·Oct 11

Guidelines are evolving: 1) China 2022: Manage H. pylori by family, not just the individual 2) Taipei II (2025): who to screen, how to treat, and follow-up after eradication 3) Maastricht VI: treat all infected people, guided by resistance testing

Liang Wang avatar
Liang Wang@_wangliang·Oct 11

Personal risk prediction, two routes: 1) Bacterial genome SNPs (528 strains) separate early (NAG/AG) from late (IM/GC) stages, with AUC 0.78–0.90 across validation sets (PNAS 2026). 2) A CatBoost model on routine lab tests predicts Correa cascade stage. A 10-feature lightweight version is available as a free web tool. It supports screening and doesn’t replace endoscopy or pathology (JMIR 2026).

Liang Wang avatar
Liang Wang@_wangliang·Oct 11

Our group's national study of 12,902 adults in 52 cities across 26 provinces used a single method: string test + qPCR. Results: 27.08% infected, 50.83% clarithromycin-resistant, 47.17% levofloxacin-resistant. Risk factors: less-developed cities, obesity, and low public awareness of H. pylori. (Wang et al., Lancet Microbe, 2024)

Liang Wang avatar
Liang Wang@_wangliang·Oct 11

H. pylori is a Class I carcinogen and a major driver of gastric cancer. China has the world’s largest burden, with ~37% of new cases and ~39% of deaths. Global infection has fallen from 58% (1980s–90s) to 43% (2011–22), and gastric cancer incidence has fallen with it.

Liang Wang avatar
Liang Wang@_wangliang·Oct 11

Giving an invited talk this Saturday on H. pylori — from population surveillance to personal risk. A nationwide screening study reported an ~27% infection rate in the urban population, with high resistance to clarithromycin (~51%) and levofloxacin (~47%). Models based on genomic SNPs and routine laboratory tests can now predict stage along the gastric cancer cascade. Expert consensus is moving toward family-based control and resistance-guided therapy. #Helicobacterpylori #GastricCancer

Post attachmentPost attachment
JoVE avatar
⟳ Liang Wang retweeted
JoVE@JoVEJournal·Oct 6

Meet Prof. @_wangliang, winner of the 2025 JoVE Researcher Innovation Award. His JoVE video article helped standardize training across 52 centers and support H. pylori screening for 12,000+ people. Apply for the 2026 award & share your research impact: info.jove.com/jove-researche…

Post attachmentPost attachmentPost attachment